Hvivo.
61 announcements.
61 announcements.
Time | Date | Ticker | Company | Announcement |
---|---|---|---|---|
07:05 | 10-04-2025 | HVO | Hvivo | Exercise of Options |
07:00 | 10-04-2025 | HVO | Hvivo | Final results |
13:51 | 26-03-2025 | HVO | Hvivo | AIM Rule 17 and Schedule 2(g) Update |
07:00 | 21-03-2025 | HVO | Hvivo | Notice of Results |
07:00 | 07-03-2025 | HVO | Hvivo | Director/PDMR Shareholding |
07:00 | 27-02-2025 | HVO | Hvivo | Acquisition of Cryostore for up to £3.2m |
07:00 | 17-02-2025 | HVO | Hvivo | £2m hMPV characterisation study contract |
07:00 | 05-02-2025 | HVO | Hvivo | Shionogi reports positive RSV trial results |
07:00 | 03-02-2025 | HVO | Hvivo | RSV contract signed with Inhalon Biopharma |
13:24 | 31-01-2025 | HVO | Hvivo | Holding(s) in Company |
07:00 | 31-01-2025 | HVO | Hvivo | Holding(s) in Company |
07:01 | 29-01-2025 | HVO | Hvivo | Acquisition: two Clinical Research Units from CRS |
07:00 | 29-01-2025 | HVO | Hvivo | Trading update |
07:00 | 27-01-2025 | HVO | Hvivo | LOI signed for Phase 3 Whooping Cough trial |
07:00 | 21-01-2025 | HVO | Hvivo | £3.2m hLAB project |
07:00 | 14-01-2025 | HVO | Hvivo | Holding(s) in Company |
07:00 | 13-01-2025 | HVO | Hvivo | hMPV challenge model update |
07:00 | 10-12-2024 | HVO | Hvivo | £11.5m RSV contract and notice of trading update |
07:00 | 19-11-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 06-11-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 11-10-2024 | HVO | Hvivo | Long Term Incentive Plan/ PDMR Notification |
07:00 | 24-09-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 17-09-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 13-09-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 10-09-2024 | HVO | Hvivo | Interim results |
07:00 | 05-09-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 20-08-2024 | HVO | Hvivo | Notice of results |
15:07 | 06-08-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 05-08-2024 | HVO | Hvivo | Euronext cancellation |
13:55 | 24-07-2024 | HVO | Hvivo | Holding(s) in Company |
14:48 | 23-07-2024 | HVO | Hvivo | Director/PDMR Shareholding |
07:01 | 17-07-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 17-07-2024 | HVO | Hvivo | Trading update |
07:00 | 08-07-2024 | HVO | Hvivo | Holding(s) in Company |
14:48 | 03-07-2024 | HVO | Hvivo | Holding(s) in Company |
07:01 | 02-07-2024 | HVO | Hvivo | Capital Markets Day & Notice of trading update |
07:02 | 02-07-2024 | HVO | Hvivo | Change of registered address |
07:00 | 02-07-2024 | HVO | Hvivo | Influenza 2b field study contract |
07:00 | 03-06-2024 | HVO | Hvivo | £2.5m contract for Omicron characterisation study |
13:02 | 13-05-2024 | HVO | Hvivo | Result of AGM |
07:09 | 09-04-2024 | HVO | Hvivo | Final results |
07:00 | 27-03-2024 | HVO | Hvivo | Notice of Results |
15:03 | 22-03-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 14-03-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 15-02-2024 | HVO | Hvivo | Long Term Incentive Plan / PDMR Notification |
13:14 | 14-02-2024 | HVO | Hvivo | Result of Secondary Placing |
07:00 | 14-02-2024 | HVO | Hvivo | Proposed Secondary Placing of Ordinary Shares |
12:44 | 02-02-2024 | HVO | Hvivo | Holding(s) in Company |
07:00 | 30-01-2024 | HVO | Hvivo | Trading update |
07:00 | 08-01-2024 | HVO | Hvivo | Broker change |
07:00 | 02-01-2024 | HVO | Hvivo | £6.3m HRV contract signed with biotech client |
07:00 | 13-12-2023 | HVO | Hvivo | £16.8m RSV contract & Trading ahead of guidance |
07:00 | 12-09-2023 | HVO | Hvivo | Interim results |
07:00 | 01-09-2023 | HVO | Hvivo | Exercise of Warrants |
07:00 | 29-08-2023 | HVO | Hvivo | Plans for a new larger state-of-the-art facility |
07:00 | 24-08-2023 | HVO | Hvivo | Notice of Results |
07:00 | 26-07-2023 | HVO | Hvivo | Trading update |
07:00 | 25-07-2023 | HVO | Hvivo | Flu B challenge model |
07:00 | 28-06-2023 | HVO | Hvivo | hMPV human challenge model |
08:00 | 14-06-2023 | HVO | Hvivo | Director dealings |
12:36 | 23-05-2023 | HVO | Hvivo | Result of AGM |